MedTrace Logo

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

NCT00446940 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2008-09-09

No results posted yet for this study

Summary

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Conditions

  • Hepatitis C

Interventions

DRUG

rosuvastatin

DRUG

atorvastatin

Sponsors & Collaborators

  • Bader, Ted, M.D.

    lead INDIV

Principal Investigators

  • Ted Bader, MD · VA Medical Center, Oklahoma City, OK

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00446940 on ClinicalTrials.gov